Approvals/CIMA-AEMPS/GLICLAZIDA AUROVITAS 60 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG

Approved

STANDARD

GLICLAZIDA AUROVITAS 60 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG

Aurovitas Spain, S.A.U.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 0094238aed7a3dd8
Drug Cima Aemps Name: GLICLAZIDA AUROVITAS 60 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG
Register Number: 88794
Holder Company Name: Aurovitas Spain, S.A.U.
Marketing Company Name: Aurovitas Spain, S.A.U.
Authorization Date: 2023-04-17
Dosage Form: COMPRIMIDO DE LIBERACIÓN MODIFICADA
Dose: 60 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración
Commercialized: Yes
Company Name: Aurovitas Spain, S.A.U.

GLICLAZIDA

60 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 17, 2023

Approval ID

0094238aed7a3dd8

Type

Standard